Vaccines efficacy to SARS-CoV-2 variants require holistic knowledge of viral immunology and protein biochemistry
The article by Abdalla et al., published in the journal on 28 May 2021, raised a concern. The SARS-CoV-2 spike (S) protein is the major targeted surface glycoprotein in COVID-19 vaccines. Many mutations in the S protein of SARS-CoV-2 have been reported across the globe. The S protein plays a crucial...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
Taylor & Francis Group,
2021-11-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|